Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 |
|---|---|---|
| Total reported revenue | 41.1M | 49.7M |
| Cost of revenue | 22.7M | 29.0M |
| Gross profit | 18.4M | 20.7M |
| Operating expense | ||
| Research & development | — | — |
| Selling general and admin | 10.3M | 10.9M |
| Other operating expenses | — | — |
| Operating income | 8.5M | 10.2M |
| Non operating interest income | ||
| Income | — | — |
| Expense | 427K | 466K |
| Other income expense | — | — |
| Pretax income | 8.1M | 9.8M |
| Tax provision | 1.8M | 2.8M |
| Net income | 6.3M | 7.0M |
| Basic EPS | 0.0 | 0.0 |
| Diluted EPS | 0.0 | 0.0 |
| Basic average shares | 666.6M | 572.0M |
| Diluted average shares | 666.6M | 572.0M |
| EBITDA | 9.7M | 10.2M |
| Net income from continuing op. | 8.1M | — |
| Minority interests | 0 | — |
| Preferred stock dividends | 0 | 0 |